Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2026 Filed Feb 10, 2026 22:02 UTC |
Kramer RobinChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 789 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000021 · form4.xml · derivative · entry 7 Kramer Robin · CIK 0001609222 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 789 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:02 UTC |
Kramer RobinChief Financial Officer
|
Tax withholdingCommon Stock | 1,063 | $201.18 | $213,854.34 |
DisclosureSEC source: 0000875045-26-000021 · form4.xml · nonDerivative · entry 6 Kramer Robin · CIK 0001609222 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,471.7483 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:02 UTC |
Kramer RobinChief Financial Officer
|
Exercise / conversionCommon Stock | 3,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000021 · form4.xml · nonDerivative · entry 5 Kramer Robin · CIK 0001609222 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,534.7483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:02 UTC |
Kramer RobinChief Financial Officer
|
Tax withholdingCommon Stock | 207 | $201.18 | $41,644.26 |
DisclosureSEC source: 0000875045-26-000021 · form4.xml · nonDerivative · entry 4 Kramer Robin · CIK 0001609222 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,023.7483 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:02 UTC |
Kramer RobinChief Financial Officer
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000021 · form4.xml · nonDerivative · entry 3 Kramer Robin · CIK 0001609222 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,230.7483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:02 UTC |
Kramer RobinChief Financial Officer
|
Tax withholdingCommon Stock | 273 | $201.18 | $54,922.14 |
DisclosureSEC source: 0000875045-26-000021 · form4.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,527.7483 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:02 UTC |
Kramer RobinChief Financial Officer
|
Exercise / conversionCommon Stock | 789 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000021 · form4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800.7483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,683 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · derivative · entry 9 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,367 Underlying: Common Stock · 4,683 shares Expires 2028-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,940 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · derivative · entry 8 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,940 Underlying: Common Stock · 1,940 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,102 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · derivative · entry 7 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,102 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Tax withholdingCommon Stock | 1,408 | $201.18 | $283,261.44 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · nonDerivative · entry 6 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,608.0408 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionCommon Stock | 4,683 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · nonDerivative · entry 5 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,016.0408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Tax withholdingCommon Stock | 914 | $201.18 | $183,878.52 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · nonDerivative · entry 4 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,333.0408 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionCommon Stock | 1,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · nonDerivative · entry 3 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,247.0408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Tax withholdingCommon Stock | 1,017 | $201.18 | $204,600.06 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · nonDerivative · entry 2 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,307.0408 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:03 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionCommon Stock | 2,102 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000022 · form4.xml · nonDerivative · entry 1 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,324.0408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 166.6667 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:01 UTC |
Keeney AdamHead of Corporate Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,278 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000020 · form4.xml · derivative · entry 6 Keeney Adam · CIK 0001973607 · Head of Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,557 Underlying: Common Stock · 3,278 shares Expires 2028-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:01 UTC |
Keeney AdamHead of Corporate Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,802 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000020 · form4.xml · derivative · entry 5 Keeney Adam · CIK 0001973607 · Head of Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,802 Underlying: Common Stock · 1,802 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:01 UTC |
Keeney AdamHead of Corporate Development
|
Tax withholdingCommon Stock | 994 | $201.18 | $199,972.92 |
DisclosureSEC source: 0000875045-26-000020 · form4.xml · nonDerivative · entry 4 Keeney Adam · CIK 0001973607 · Head of Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,881 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:01 UTC |
Keeney AdamHead of Corporate Development
|
Exercise / conversionCommon Stock | 3,278 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000020 · form4.xml · nonDerivative · entry 3 Keeney Adam · CIK 0001973607 · Head of Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:01 UTC |
Keeney AdamHead of Corporate Development
|
Tax withholdingCommon Stock | 589 | $201.18 | $118,495.02 |
DisclosureSEC source: 0000875045-26-000020 · form4.xml · nonDerivative · entry 2 Keeney Adam · CIK 0001973607 · Head of Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,597 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:01 UTC |
Keeney AdamHead of Corporate Development
|
Exercise / conversionCommon Stock | 1,802 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000020 · form4.xml · nonDerivative · entry 1 Keeney Adam · CIK 0001973607 · Head of Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,043 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · derivative · entry 9 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,087 Underlying: Common Stock · 3,043 shares Expires 2028-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,802 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · derivative · entry 8 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,802 Underlying: Common Stock · 1,802 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,044 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · derivative · entry 7 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,044 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Tax withholdingCommon Stock | 775 | $201.18 | $155,914.50 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · nonDerivative · entry 6 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,011 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionCommon Stock | 3,043 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · nonDerivative · entry 5 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Tax withholdingCommon Stock | 458 | $201.18 | $92,140.44 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · nonDerivative · entry 4 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,743 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionCommon Stock | 1,802 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · nonDerivative · entry 3 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Tax withholdingCommon Stock | 805 | $201.18 | $161,949.90 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · nonDerivative · entry 2 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,399 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 22:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionCommon Stock | 2,044 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000019 · form4.xml · nonDerivative · entry 1 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:59 UTC |
Grogan JaneHead of Research
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,873 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000018 · form4.xml · derivative · entry 6 Grogan Jane · CIK 0001995547 · Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,747 Underlying: Common Stock · 1,873 shares Expires 2028-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:59 UTC |
Grogan JaneHead of Research
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,385 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000018 · form4.xml · derivative · entry 5 Grogan Jane · CIK 0001995547 · Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,385 Underlying: Common Stock · 1,385 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:59 UTC |
Grogan JaneHead of Research
|
Tax withholdingCommon Stock | 584 | $201.18 | $117,489.12 |
DisclosureSEC source: 0000875045-26-000018 · form4.xml · nonDerivative · entry 4 Grogan Jane · CIK 0001995547 · Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,058 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:59 UTC |
Grogan JaneHead of Research
|
Exercise / conversionCommon Stock | 1,873 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000018 · form4.xml · nonDerivative · entry 3 Grogan Jane · CIK 0001995547 · Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:59 UTC |
Grogan JaneHead of Research
|
Tax withholdingCommon Stock | 407 | $201.18 | $81,880.26 |
DisclosureSEC source: 0000875045-26-000018 · form4.xml · nonDerivative · entry 2 Grogan Jane · CIK 0001995547 · Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,769 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:59 UTC |
Grogan JaneHead of Research
|
Exercise / conversionCommon Stock | 1,385 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000018 · form4.xml · nonDerivative · entry 1 Grogan Jane · CIK 0001995547 · Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,746 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · derivative · entry 9 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,494 Underlying: Common Stock · 3,746 shares Expires 2028-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,802 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · derivative · entry 8 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,802 Underlying: Common Stock · 1,802 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,635 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · derivative · entry 7 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,635 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Tax withholdingCommon Stock | 1,132 | $201.18 | $227,735.76 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · nonDerivative · entry 6 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,358.7673 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionCommon Stock | 3,746 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · nonDerivative · entry 5 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,490.7673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Tax withholdingCommon Stock | 666 | $201.18 | $133,985.88 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · nonDerivative · entry 4 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,744.7673 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionCommon Stock | 1,802 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · nonDerivative · entry 3 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,410.7673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Tax withholdingCommon Stock | 791 | $201.18 | $159,133.38 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · nonDerivative · entry 2 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,608.7673 Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionCommon Stock | 1,635 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000017 · form4.xml · nonDerivative · entry 1 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,399.7673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 166.6667 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:56 UTC |
Godbout SeanChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 517 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000016 · form4.xml · derivative · entry 9 Godbout Sean · CIK 0002057736 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,035 Underlying: Common Stock · 517 shares Expires 2028-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/06/2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:56 UTC |
Godbout SeanChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 305 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000016 · form4.xml · derivative · entry 8 Godbout Sean · CIK 0002057736 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305 Underlying: Common Stock · 305 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/07/2024. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:56 UTC |
Godbout SeanChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 257 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000016 · form4.xml · derivative · entry 7 Godbout Sean · CIK 0002057736 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 257 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:56 UTC |
Godbout SeanChief Accounting Officer
|
Tax withholdingCommon Stock | 180 | $201.18 | $36,212.40 |
DisclosureSEC source: 0000875045-26-000016 · form4.xml · nonDerivative · entry 6 Godbout Sean · CIK 0002057736 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,214.6667 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.